VAPO Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 15.80%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Vapotherm Insider Trading History Chart

This chart shows the insider buying and selling history at Vapotherm by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$500k$0$500kTotal Insider BuyingTotal Insider Selling

Vapotherm Share Price & Price History

Current Price: $2.17
Price Change: Price Decrease of -0.01 (-0.46%)
As of 09/19/2024 10:06 PM ET

This chart shows the closing price history over time for VAPO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

SEC Filings (Institutional Ownership Changes) for Vapotherm (NYSE:VAPO)

43.08% of Vapotherm stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at VAPO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
202220232024$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4-$5M$0$5MTotal InflowsTotal Outflows
Vapotherm logo
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers High Velocity Therapy systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, and Precision Flow Classic which delivers non-invasive ventilatory support to patients by providing heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor that provides compressed air necessary to run the precision flow systems in areas of the hospital without access to a wall gas source; aerosol aeroneb adaptor to facilitate delivery of aerosolized solutions; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol solutions for patients; and tracheostomy adaptors that simplifies the connection of the High Velocity Therapy systems to a tracheostomy collar used to wean patients off mechanical ventilation. In addition, the company offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Module, which helps clinicians maintain oxygen levels within a target range. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.
Read More on Vapotherm

Today's Range

Now: $2.17
Low: $2.16
High: $2.17

50 Day Range

MA: $2.16
Low: $2.13
High: $2.18

52 Week Range

Now: $2.17
Low: $0.70
High: $3.44

Volume

51,500 shs

Average Volume

N/A

Market Capitalization

$13.58 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Vapotherm?

Vapotherm's top insider investors include:
  1. Joseph Army (CEO)
  2. Anthony L Arnerich (Director)
Learn More about top insider investors at Vapotherm.